Hamman-Rich Syndrome: Clinical Trials

1 completed. 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	1	Completed 1

Follow Hamman-Rich Syndrome: new trials by email Literature Review of Hamman-Rich Syndrome trials Research Report on Hamman-Rich Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Bardoxolone methyl, Placebo - Pulmonary Arterial Hypertension, Pulmonary Hypertension	Phase 2	Completed	Biogen	166	2014-05-31	2025-06-10

Narrower conditions

Cryptogenic Organizing Pneumonia (1)  ·  Hypertension, Pulmonary (1)  ·  Idiopathic Interstitial Pneumonias (1)  ·  Idiopathic Pulmonary Fibrosis (1)  ·  Interstitial Pneumonitis, Desquamative, Familial (1)  ·  Lung Diseases, Interstitial (1)  ·  Pulmonary Arterial Hypertension (1)  ·  Sarcoidosis (1)

Broader conditions

Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchiolitis Obliterans (1)  ·  Bronchitis (1)  ·  Cardiovascular Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Delayed (1)  ·  Hypertension (1)  ·  Immune System Diseases (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Organizing Pneumonia (1)

Interventions

ORF 50 transactivator (1)  ·  bardoxolone methyl (1)

Sponsors

Biogen (1)

Countries

Germany (1)  ·  United States (1)